Back to today’s briefing

Story perspectives

Gene Editing Enables Long-Term Obesity Treatment Breakthrough

7/14/2025

50 3

Summary

Story summary

In a groundbreaking study, University of Osaka researchers have harnessed genome editing to implant a gene in mouse liver cells, leading to continuous production of exenatide—a promising drug for obesity and pre-diabetes. Remarkably, treated mice maintained better weight control and glucose metabolism for over six months, paving the way for less frequent treatments.

1 of 1

Story summary

In a groundbreaking study, University of Osaka researchers have harnessed genome editing to implant a gene in mouse liver cells, leading to continuous production of exenatide—a promising drug for obesity and pre-diabetes. Remarkably, treated mice maintained better weight control and glucose metabolism for over six months, paving the way for less frequent treatments.